Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
ncarol.com/10258250

DURHAM, N.C., April 16, 2024 ~ Prime Healthcare and EmVenio Research have joined forces to launch the EmVenio Research Center at Prime Healthcare, a new initiative that aims to improve access to clinical research for patients while also expanding the research capabilities of Prime Healthcare hospitals.

EmVenio Research, a community research provider, will now have the opportunity to conduct research at Prime Healthcare hospitals and offer patients improved access to clinical trials. This partnership is expected to increase participation in clinical trials by creating awareness of research within communities and providing local access to global research opportunities.

With 44 hospitals and over 300 outpatient locations across the United States, Prime Healthcare is one of the nation's leading health systems. Known for its commitment to quality excellence and innovation, Prime Healthcare will provide the necessary infrastructure and clinical support for EmVenio Research to conduct advanced clinical trials.

Through this collaboration, EmVenio will work with Prime Healthcare hospitals to identify potential candidates for clinical trials using Health Wizz. This secure platform connects with Electronic Health Records (EHR) systems, protecting patient data while streamlining the process of identifying, screening, and enrolling study participants. All data collected will be kept secure and used only with patient consent.

More on ncarol.com

• Award-Winning Couture Master Perfumer JoAnne Bassett Launches All-Natural DIY Perfume Making Kits
• Couture Master Perfumer JoAnne Bassett Offers Rare Opportunity to Acquire 70 Formula Perfume Codex
• Slotozilla Reports Strong Growth in Q2 2026
• Flexible Plan Investments Names Carl Resnick President
• Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety

Thad Wolfram, President of EmVenio Research, expressed his excitement about this partnership stating that their priority is delivering value to communities while successfully enrolling and retaining patients for their customers. He believes that through this collaboration with Prime Healthcare and Health Wizz, EmVenio will expand its community-based research footprint and be able to recruit an ever-growing patient base for clinical trials.

Dr. Sunny Bhatia, President and Chief Medical Officer of Prime Healthcare, also shared his enthusiasm about this partnership. He believes that EmVenio's expertise in designing and implementing clinical studies will keep the EmVenio Research Center at Prime Healthcare at the forefront of medical research and discovery. Dr. Bhatia hopes that by offering these opportunities to patients at Prime hospitals, they will have better clinical experiences and outcomes.

Nitin Desai, MD, President and Chief Medical Officer of Health Wizz, also expressed his pride in being a part of this visionary collaboration. He believes that by integrating their technology solutions, they can enhance the efficiency and security of enrolling study participants in clinical trials, ultimately benefiting both patients and researchers.

More on ncarol.com

• Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
• No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
• The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
• Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
• FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)

The EmVenio Research Center at Prime Healthcare will make clinical research available to patients at Prime hospitals across the country, starting with California, Alabama, Texas, and Georgia. This will provide clinical trial sponsors and Contract Research Organizations (CROs) with access to a large and diverse patient population that was previously unavailable to them. With the detailed data available through this partnership, it is expected that there will be improved study feasibility, leading to reduced screen failure rates and increased enrollment certainty.

This service offering includes a hybrid approach that seamlessly integrates brick-and-mortar sites, mobile sites, and in-home research. This unique collaboration between EmVenio Research, Prime Healthcare, and Health Wizz marks a significant milestone in EmVenio's evolution and service repertoire.

Wolfram believes that the EmVenio Research Center at Prime Healthcare will set them apart for patients, communities, partners, and clients alike. This partnership is expected to bring about positive changes in the world of clinical research by providing better opportunities for patients while also expanding research capabilities for healthcare providers.

---

Show All News | Disclaimer | Report Violation